[1]戴云秀,杨光杰,王振光,等.18F-FDG PET/CT基线SUVmax在滤泡性淋巴瘤侵袭性、分期评价中的价值及其与中期疗效的相关性研究[J].国际放射医学核医学杂志,2018,(2):104-110.[doi:10.3760/cma.j.issn.1673-4114.2018.02.002]
　Dai Yunxiu,Yang Guangjie,Wang Zhenguang,et al.Evaluation of invasiveness, staging, and correlation with interim therapeutic response based on baseline 18F-FDG PET/CT SUVmax in patients with follicular lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):104-110.[doi:10.3760/cma.j.issn.1673-4114.2018.02.002]
点击复制

18F-FDG PET/CT基线SUVmax在滤泡性淋巴瘤侵袭性、分期评价中的价值及其与中期疗效的相关性研究(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
期数:
2018年第2期
页码:
104-110
栏目:
临床研究
出版日期:
2018-05-09

文章信息/Info

Title:
Evaluation of invasiveness, staging, and correlation with interim therapeutic response based on baseline 18F-FDG PET/CT SUVmax in patients with follicular lymphoma
作者:
戴云秀;  杨光杰;  王振光;  赵钰鋆;  于明明;  李大成;  武凤玉;  刘思敏
266000, 青岛大学附属医院PET/CT中心
Author(s):
Dai Yunxiu;  Yang Guangjie;  Wang Zhenguang;  Zhao Yujun;  Yu Mingming;  Li Dacheng;  Wu Fengyu;  Liu Simin
PET/CT Center, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
关键词:
正电子发射断层显像术; 体层摄影术; X线计算机; 标准化摄取值; 疗效评价; 滤泡性淋巴瘤
Keywords:
Positron-emission tomography; Tomography;  X-ray computed; Standardized uptake value; Response assessment; Follicular lymphoma
DOI:
10.3760/cma.j.issn.1673-4114.2018.02.002
摘要:
目的 探讨18F-FDG PET/CT基线最大标准化摄取值（SUVmax）在评估滤泡性淋巴瘤（FL）侵袭性、临床分期中的应用价值及其与R-CHOP （利妥昔单抗联合环磷酰胺、阿霉素、长春新碱和泼尼松）化疗方案中期疗效的相关性。方法 回顾性研究R-CHOP方案化疗前行基线18F-FDG PET/CT检查的FL患者48例，其中18例患者在3个周期R-CHOP化疗后再次行18F-FDG PET/CT检查进行疗效评估。应用两个独立样本t检验和Mann-Whitney U检验评价低级别FL组（病理分级为1~2级、3a级）与高级别FL组（病理分级为3b级及以上）、局限期组与播散期组、完全缓解组与非完全缓解组患者的基线SUVmax差异；应用Spearman相关分析评价基线SUVmax与不同Ann Arbor分期的相关性。结果 低级别FL组与高级别FL组患者的基线SUVmax差异有统计学意义（6.23±4.68 vs.13.20±6.68，t=3.919，P<0.001），受试者工作特征曲线（ROC）下面积为0.835。基线SUVmax与Ann Arbor分期无显著相关性（r=0.242，P=0.098）。低级别FL患者中局限期组的基线SUVmax明显低于播散期组，差异有统计学意义（中位数1.20 vs.7.85，U=24.000，P<0.001），ROC曲线下面积为0.905。R-CHOP中期化疗后疗效完全缓解组的基线SUVmax明显低于非完全缓解组，差异有统计学意义（5.16±3.05 vs.10.99±7.45，t=2.172，P=0.045）。结论 18F-FDG PET/CT基线SUVmax可有效评估FL的侵袭性，并与R-CHOP方案的中期疗效、低级别FL患者的病变播散程度密切相关。
Abstract:
Objective To study the value of baseline 18F-FDG PET/CT maximum standardized uptake value (SUVmax) in evaluating the invasiveness, staging, and correlation between baseline SUVmax and the interim therapeutic response in patients with follicular lymphoma (FL). Methods Forty-eight FL patients who underwent baseline 18F-FDG PET/CT scan before chemotherapy, with the combination regimen of rituximab, cyclophosphamide, hydroxydaunomycin, oncovin and prednisolone (R-CHOP), were studied. Eighteen patients underwent 18F-FDG PET/CT scan again after 3 cycles of R-CHOP treatment to evaluate the interim therapeutic response. Two-sample t-test and Mann-Whitney U test were used to evaluate the differences in the baseline SUVmax between the following:low-grade group (pathological grades 1-2 and 3a) and high-grade group (pathological grade not lower than grade 3b); non-disseminated stage group and disseminated stage group; and complete response (CR) group and non-CR group. Spearman’s rank correlation coefficient was used to estimate the relation between the baseline SUVmax and the Ann Arbor staging. Results The baseline SUVmax was significantly different between the low-and high-grade groups (6.23±4.68 vs. 13.20±6.68, t=3.919, P<0.001), and the area under the receiver operating characteristic curve (AUC) was 0.835. No significant relation was found between the baseline SUVmax and the Ann Arbor staging (r=0.242, P=0.098). The baseline SUVmax of the non-disseminated stage group was significantly lower than that of the disseminated stage group among low-grade FL patients (median:1.20 vs. 7.85, U=24.000, P<0.001), and the AUC was 0.905. The baseline SUVmax of the CR group was significantly lower than that of the non-CR group after the interim R-CHOP therapy (5.16±3.05 vs. 10.99±7.45, t=2.172, P=0.045). Conclusions The baseline 18F-FDG PET/CT SUVmax is effective in evaluating invasiveness and staging and is related to the interim therapeutic response among FL patients. Moreover, the baseline SUVmax is related to the disease dissemination among low-grade FL patients.

参考文献/References:

[1] 中华医学会血液学分会, 中国抗癌协会淋巴瘤专业委员会. 中国滤泡性淋巴瘤诊断与治疗指南(2013年版)[J]. 中华血液学杂志, 2013, 34(9):820-824. DOI:10.3760/cma.j.issn.0253-2727. 2013. 09.020. Chinese Society of Hematology, Chinese Medical Association, Chinese Society of Lymphoma, Chinese Anti-cancer Association. Chinese guidelines for diagnosis and treatment of follicular lymphoma(2013)[J]. Chin J Hematol, 2013, 34(9):820-824.
[2] 叶琇锦, 钱文斌. 滤泡性淋巴瘤预后和分层治疗策略[J]. 中国实用内科杂志, 2015, 35(2):99-101. DOI:10.7504/nk2015010105. Ye XJ, Qian WB. The current prognostic tools and strategy for treating follicular lymphoma[J]. Chin J Pract Intern Med, 2015, 35(2):99-101.
[3] Mendez M, Torrente M, Provencio M. Follicular lymphomas and their transformation:Past and current research[J]. Expert Rev Hematol, 2017, 10(6):515-524. DOI:10.1080/17474086.2017.1326812.
[4] Yang G, Nie P, Wang Z, et al. 18F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma[J]. Eur J Nucl Med Mol Imaging, 2016, 43(10):1928. DOI:10.1007/s00259-016-3399-0.
[5] 刘青青, 王振光, 王楠, 等. 非霍奇金淋巴瘤与广泛淋巴结转移癌的18F-FDG PET/CT淋巴结影像特征比较[J]. 中华核医学与分子影像杂志, 2016, 36(2):142-145. DOI:10.3760/cma.j.issn.2095-2848.2016.02.010. Liu QQ, Wang ZG, Wang N, et al. Characteristics of lymph nodes on 18F-FDG PET/CT imaging in patients with non-Hodgkin’s lymphoma and widespread lymph node metastases carcinoma[J]. Chin J Nucl Med Mol Imaging, 2016, 36(2):142-145.
[6] 吕清湖, 唐明灯, 林端瑜, 等. 原发鼻咽淋巴瘤与鼻咽癌的18F-FDG PET/CT诊断与鉴别[J]. 国际放射医学核医学杂志, 2017, 41(3):166-172. DOI:10.3760/cma.j.issn.1673-4114.2017.03.002. Lyu QH, Tang MD, Lin DY, et al. Value of 18F-FDG PET/CT examination in the differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma[J]. Int J Radiat Med Nucl Med, 2017, 41(3):166-172.
[7] 秦文琼, 高硕. PET/CT与临床预后因素在弥漫大B细胞淋巴瘤疗效评价及预后评估中的应用[J]. 国际放射医学核医学杂志,2017, 41(6):437-442. DOI:10.3760/cma.j.issn.1673-4114. 2017. 06.010. Qin WQ, Gao S. Application of PET/CT and clinical factors in the therapeutic and prognostic evaluation of diffuse large B cell lymphoma[J]. Int J Radiat Med Nucl Med, 2017, 41(6):437-442.
[8] Younes A, Hilden P, Coiffier B, et al. International Working Group consensus response evaluation criteria in lymphoma(RECIL 2017)[J]. Ann Oncol, 2017, 28(7):1436-1447. DOI:10.1093/annonc/mdx097.
[9] 中华医学会核医学分会PET与分子影像学组. 淋巴瘤18F-FDG PET/CT显像临床应用指南(2016版)[J]. 中华核医学与分子影像杂志, 2016, 36(5):458-460. DOI:10.3760/cma.j.issn.2095-2848. 2016.05.017. Imaging Group of Chinese Society of Nuclear Medicine. Clinical practice guideline of 18F-FDG PET/CT in lymphoma(2016 edition)[J]. Chin J Nucl Med Mol Imaging, 2016, 36(5):458-460.
[10] Jaffe ES. The 2008 WHO classification of lymphomas:implications for clinical practice and translational research[J]. Hematology Am Soc Hematol Educ Program, 2009, 2009(1):523-531. DOI:10.1182/asheducation-2009.1.523.
[11] Finn WG, Kroft SH. New classifications for non-Hodgkin’s lymphoma[J]. Cancer Treat Res, 1999, 99(99):1-26. DOI:10.1007/978-0-585-38571-6_1.
[12] O JH, Lodge MA, Wahl RL. Practical PERCIST:A Simplified Guide to PET Response Criteria in Solid Tumors 1.0[J]. Radiology, 2016, 280(2):576-584. DOI:10.1148/radiol.2016142043.
[13] Takata K, Miyata-Takata T, Sato Y, et al. Pathology of follicular lymphoma[J]. J Clin Exp Hematop, 2014, 54(1):3-9. DOI:10.3960/jslrt.54.3.
[14] Fischer T, Zing NPC, Chiattone CS, et al. Transformed follicular lymphoma[J]. Ann Hematol, 2018, 97(1):17-29. DOI:10.1007/s00277-017-3151-2.
[15] 戴娜, 吴翼伟, 章斌. 18F-FDG PET/CT对不同分级和分期滤泡性淋巴瘤诊断及预后评估的价值[J]. 中华核医学与分子影像杂志, 2014, 34(1):23-26. DOI:10.3760/cma.j.issn.2095-2848. 2014. 01. 008. Dai N, Wu YW, Zhang B. Grading, staging and prognosis of follicular lymphoma:the value of 18F-FDG PET/CT[J]. Chin J Nucl Med Mol Imaging, 2014, 34(1):23-26.
[16] 丁重阳, 李天女, 孙晋,等. 18F-FDG PET/CT在滤泡性淋巴瘤分期及疗效评价中的临床价值[J]. 中华核医学与分子影像杂志, 2014, 34(3):179-182. DOI:10.3760/cma.j.issn.2095-2848. 2014. 03.005. Ding CY, Li TN, Sun J, et al. Clinical value of 18F-FDG PET/CT in clinical staging and therapeutic evaluation of follicular lymphoma[J]. Chin J Nucl Med Mol Imaging, 2014, 34(3):179-182.
[17] Rodriguez M, Rehn S, Ahlström H, et al. Predicting malignancy grade with PET in non-Hodgkin’s lymphoma[J]. J Nucl Med, 1995, 36(10):1790-1796.
[18] Minamimoto R, Fayad L, Advani R, et al. Diffuse large B-Cell lymphoma:prospective multicenter comparison of early interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, deauville, and PERCIST criteria for early therapeutic monitoring[J]. Radiology, 2016, 280(1):220-229. DOI:10.1148/radiol.2015150689.
[19] Suh C, Kang YK, Roh JL, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck[J]. J Nucl Med, 2008, 49(11):1783-1789. DOI:10.2967/jnumed.108.053355.
[20] Ahmadzadehfar H, Rodrigues M, Zakavi R, et al. Prognostic significance of the standardized uptake value of pre-therapeutic 18F-FDG PET in patients with malignant lymphoma[J]. Med Oncol, 2011, 28(4):1570-1576. DOI:10.1007/s12032-010-9584-2.
[21] Tychyj-Pinel C, Ricard F, Fulham M, et al. PET/CT assessment in follicular lymphoma using standardized criteria:central review in the PRIMA study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(3):408-415. DOI:10.1007/s00259-013-2441-8.
[22] Angelopoulou MK, Mosa E, Pangalis GA, et al. The significance of PET/CT in the initial staging of hodgkin lymphoma:experience outside clinical trials[J]. Anticancer Res, 2017, 37(10):5727-5736. DOI:10.21873/anticanres.12011.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
　Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
　Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[5]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
　Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[6]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
　Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[7]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
　Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[8]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
　Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[9]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
　Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[10]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
　Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[11]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
　Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[12]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
　Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[13]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[14]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
　Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[15]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
　Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[16]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
　zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[17]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
　Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[18]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
　Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[19]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
　Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[20]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
　Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]

备注/Memo

备注/Memo:
收稿日期:2017-11-07。
基金项目:国家自然科学基金（81601527）；山东省自然科学基金（ZR2017MH036）
通讯作者:王振光,Email:doctorwzg2002@hotmail.com
更新日期/Last Update: 2018-05-09